Association Between Cardiovascular Magnetic Resonance‐Derived Left Atrial Dimensions, Electroanatomical Substrate and NT‐proANP Levels in Atrial Fibrillation

Background Enlargement of left atrial (LA) size indicates advanced disease stage in patients with atrial fibrillation (AF) and is associated with poor success of different AF therapies. Two dimensional echocardiographic LA measurements do not reliably reflect the true size of LA anatomy. The aim of the current study was: 1) to analyze cardiovascular magnetic resonance (CMR)‐derived LA dimensions and their association with low voltage areas (LVA); and 2) to investigate the association between these parameters and NT‐proANP (N‐terminal proatrial natriuretic peptide) levels. Methods and Results Patients undergoing first AF catheter ablation were included. All patients underwent CMR imaging (Ingenia 1.5T Philips) before intervention. CMR data (LA volume, superior–inferior, transversal and anterior–posterior LA diameters) were measured in all patients. LVA were determined using high‐density maps and a low voltage threshold <0.5 mV. Blood plasma samples from femoral vein were collected before catheter ablation. NT‐proANP levels were studied using commercially available assays. There were 216 patients (65±11 years, 59% males, 56% persistent AF, 26% LVA) included into analyses. NT‐proANP levels in patients with LVA were significantly higher than in those without (median/interquartile range 22 [13–29] versus 15 [9–22] pg/mL, P=0.004). All CMR derived LA diameters correlated significantly with persistent AF (r²=0.291–0.468, all P<0.001), LVA (r²=0.187–0.306, all P<0.001), and NT‐proANP levels (r²=0.258–0.352, P<0.01). On logistic regression multivariable analysis, age (odds ratio=1.090, 95% confidence interval: 1.030–1.153, P=0.003), females (odds ratio=2.686, 95% confidence interval: 1.047–6.891, P=0.040), and LA volume (odds ratio=1.022, 95% confidence interval: 1.009–1.035, P=0.001) remained significant predictors for LVA. Conclusions Left atrial CMR parameters are associated with persistent AF, low voltage areas and NT‐proANP levels. LA volume is the most significant predictor for LVA.

[1]  G. Hindricks,et al.  Individually tailored vs. standardized substrate modification during radiofrequency catheter ablation for atrial fibrillation: a randomized study , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[2]  G. Hindricks,et al.  Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes. , 2018, Heart rhythm.

[3]  G. Hindricks,et al.  Prediction of electro-anatomical substrate using APPLE score and biomarkers , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  C. Piorkowski,et al.  Prevalence and predictors of low voltage zones in the left atrium in patients with atrial fibrillation , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[5]  Yinglong Hou,et al.  Association of pre-ablation level of vitamin D with atrial fibrillation recurrence after catheter ablation: reply. , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  E. Guasch,et al.  P892Predominant distribution of atrial fibrosis around the left inferior pulmonary vein identified by LGE-MRI in patients with atrial fibrilation , 2017 .

[7]  Ulrich Schotten,et al.  2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS. , 2017, Revista espanola de cardiologia.

[8]  F. Triposkiadis.  Biomarkers in Heart Failure with Preserved Ejection Fraction: Problems and Opportunities , 2016, Cardiology.

[9]  G. Lip,et al.  Association between peripheral plasma markers and left atrial anatomy in patients with atrial fibrillation. , 2016, International journal of cardiology.

[10]  G. Hindricks,et al.  Comparison of left atrial dimensions in CT and echocardiography as predictors of long-term success after catheter ablation of atrial fibrillation , 2015, Journal of Interventional Cardiac Electrophysiology.

[11]  G. Hindricks,et al.  Impact of asymmetrical dilatation of the left atrium on the long-term success after catheter ablation of atrial fibrillation. , 2015, International journal of cardiology.

[12]  A. Bashir,et al.  Left atrial volume assessment in atrial fibrillation using multimodality imaging: a comparison of echocardiography, invasive three-dimensional CARTO and cardiac magnetic resonance imaging , 2015, The International Journal of Cardiovascular Imaging.

[13]  Christopher Piorkowski,et al.  Tailored Atrial Substrate Modification Based on Low-Voltage Areas in Catheter Ablation of Atrial Fibrillation , 2014, Circulation. Arrhythmia and electrophysiology.

[14]  G. Hindricks,et al.  Impact of Metabolic Syndrome on Left Atrial Electroanatomical Remodeling and Outcomes After Radiofrequency Ablation of Nonvalvular Atrial Fibrillation , 2014, Circulation. Arrhythmia and electrophysiology.

[15]  E. Halpern,et al.  Impact of left atrial volume on outcomes of pulmonary vein isolation in patients with non-paroxysmal (persistent) and paroxysmal atrial fibrillation. , 2013, The American journal of cardiology.

[16]  R. Hunter,et al.  Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation?: a meta-analysis. , 2013, International journal of cardiology.

[17]  C. Granger,et al.  Biomarkers in atrial fibrillation: a clinical review. , 2013, European heart journal.

[18]  Yawei Xu,et al.  Association between left atrial size and atrial fibrillation recurrence after single circumferential pulmonary vein isolation: a systematic review and meta-analysis of observational studies. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[19]  R. Hunter,et al.  Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death , 2011, Heart.

[20]  E. Fleck,et al.  Cardiovascular magnetic resonance imaging for accurate sizing of the left atrium: Predictability of pulmonary vein isolation success in patients with atrial fibrillation , 2011, Journal of magnetic resonance imaging : JMRI.

[21]  Jeroen J. Bax,et al.  Left atrial size as a predictor of successful radiofrequency catheter ablation for atrial fibrillation. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[22]  P. Schauerte,et al.  Association of echocardiographic atrial size and atrial fibrosis in a sequential model of congestive heart failure and atrial fibrillation. , 2008, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[23]  David Tamborero,et al.  Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. , 2007, European heart journal.

[24]  James B Seward,et al.  Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up. , 2006, European heart journal.

[25]  C. Tai,et al.  The Mechanisms of an Increased Dominant Frequency in the Left Atrial Posterior Wall During Atrial Fibrillation in Acute Atrial Dilatation , 2006, Journal of cardiovascular electrophysiology.

[26]  N. Maeda,et al.  The role of natriuretic peptides in cardioprotection. , 2006, Cardiovascular research.

[27]  H. Calkins,et al.  The Extent of Left Atrial Low-Voltage Areas Included in Pulmonary Vein Isolation Is Associated With Freedom from Recurrent Atrial Arrhythmia. , 2018, The Canadian journal of cardiology.

[28]  David D Spragg,et al.  Multimodal Examination of Atrial Fibrillation Substrate: Correlation of Left Atrial Bipolar Voltage Using Multi-Electrode Fast Automated Mapping, Point-by-Point Mapping, and Magnetic Resonance Image Intensity Ratio. , 2018, JACC. Clinical electrophysiology.

[29]  L. R. Potter,et al.  Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. , 2009, Handbook of experimental pharmacology.